Pfizer chairman promises improved share price

MEMPHIS, Tenn. Yesterday at Pfizer’s annual shareholder meeting, chairman and chief executive officer Jeffrey Kindler detailed his plan to build on the company’s foundation to drive greater shareholder return.

“Operationally, in 2007, we took a series of significant actions to better position Pfizer to meet our challenges and to seize the many opportunities before us in the growing global marketplace for better healthcare,” Kindler said. “Of course, we are far from done—and our progress is not yet reflected in the share price.”

At the meeting, the company’s 14 directors were re-elected to one-year terms. In other voting, shareholders ratified the selection of KPMG as Pfizer’s independent registered public accounting firm for the 2008 fiscal year. The two shareholder resolutions did not receive a majority vote.